Another strategy in NEC treatment utilized simulated amniotic fluid and yielded promising results, likely through targeting mucosal protection conferred by amniotic fluid, which is rich in growth factors and exerts anti-TLR4 effects (75). The gene discussed is TLR4; the disease is necrotizing enterocolitis.